Cerebrospinal fluid neurogranin and TREM2 in Huntington’s disease-Reference-Cited by-同舟云学术

Cerebrospinal fluid neurogranin and TREM2 in Huntington’s disease

Published:2018-03-09 Issue:1 Volume:8 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Byrne Lauren M.,Rodrigues Filipe B.,Johnson Eileanoir B.,De Vita Enrico,Blennow Kaj,Scahill Rachael,Zetterberg Henrik,Heslegrave Amanda,Wild Edward J.^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/s41598-018-21788-x.pdf

Reference43 articles.

1. Bates, G. P. et al. Huntington disease. Nat Rev Dis Primers 1, 15005 (2015).

2. Milnerwood, A. J. & Raymond, L. A. Early synaptic pathophysiology in neurodegeneration: insights from Huntington’s disease. Trends Neurosci 33, 513–523 (2010).

3. Dalrymple, A. et al. Proteomic profiling of plasma in Huntington’s disease reveals neuroinflammatory activation and biomarker candidates. J Proteome Res 6, 2833–2840 (2007).

4. Bjorkqvist, M. et al. A novel pathogenic pathway of immune activation detectable before clinical onset in Huntington’s disease. The Journal of experimental medicine 205, 1869–1877 (2008).

5. Traeger, U. et al. HTT-lowering reverses Huntington’s disease immune dysfunction caused by NFKB-pathway dysregulation. Brain 137, 819–33 (2014).

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biomarkers in neurodegenerative diseases: a broad overview;Exploration of Neuroprotective Therapy;2024-04-16

2. Unveiling brain disorders using liquid biopsy and Raman spectroscopy;Nanoscale;2024

3. A unified classification approach rating clinical utility of protein biomarkers across neurologic diseases;eBioMedicine;2023-03

4. The diagnostic and prognostic value of serum neurogranin in acute ischemic stroke;Journal of Stroke and Cerebrovascular Diseases;2023-02

5. Cerebrospinal Fluid Biomarkers in Huntington’s Disease;Contemporary Clinical Neuroscience;2023